Ikena Oncology Inc. (IKNA): P/S multiplikatori

ikenaoncology.com (IKNA) brendining ramzi va logotipi

P/S grafigi Ikena Oncology, Inc. (IKNA) kompaniyasining moliyaviy barqarorligini tasdiqlaydi, uning naqd pul zaxiralari ishlab chiqish xarajatlarini to'liq qoplaydi. Joriy 104.50 farmatsevtika bozori sog'liqni saqlash gigantlari bilan qattiq raqobat sharoitida ushbu ko'rsatkichning holatini aks ettiradi. Daromad keltiruvchi mahsulotlarning yo'qligi kompaniyani klinik sinovlarga tizimli ravishda kapital sarflashga majbur qiladi, bu esa ma'lum darajadagi operatsion inertsalikni yuzaga keltiradi.

IKNA Ikena Narxning daromadga nisbati (04.07.2022 - 07.03.2025)

Ikena Oncology Inc. (IKNA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning fundamental tahlili:IKNA - Ikena Oncology, Inc.
Ikena Oncology brend mahsuloti

Ikena Oncology, Inc. (IKNA) kompaniyasining fundamental qiymatini ob'ektiv baholash uchun investorlar bozor kapitalizatsiyasining yillik savdolarga nisbatini tahlil qilishlari kerak. Kompaniyaning joriy P/S ko'rsatkichini tahlil qilishda, ushbu nisbat daromadga nisbatan bozor premiumini o'lchashi ta'kidlanishi lozim, bunda ko'rsatkichlarning oshishi akademik markazlar bilan birgalikda saratonga qarshi dori vositalarini ishlab chiqishda kutilayotgan ulkan muvaffaqiyatlar signalini beradi.

Ikena Oncology, Inc. raqobatchilari

ONC - Sotuvga nisbatan narx|P/S multiplikatori HALO (Halozyme Therapeutics, Inc.)|Revolution Medicines (RVMD) - Sotuvga nisbatan narx|ascentage.com - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati CGON (cgoncology.com)|URGN: P/S multiplikatori|Bicara Therapeutics Inc (BCAX) - P/S multiplikatori|Narxning daromadga nisbati personalis.com|Kapitalizatsiyaning daromadga nisbati Erasca Corp (ERAS)|Kapitalizatsiyaning daromadga nisbati DCTH (Delcath)|Narx/daromad koeffitsiyenti Y-mAbs Therapeutics, Inc.|P/S multiplikatori AURA (Aura Biosciences Inc)|Bozor kapitallashuvining daromadga nisbati CADL|ARAY: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti sellaslifesciences.com SLS|ACTU (Actuate Therapeutics, Inc) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiya va daromad nisbati CTOR|Narxning daromadga nisbati TuHURA Biosciences Inc.|TARA: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Fate Therapeutics (FATE)|Narx/daromad koeffitsiyenti Aadi Bioscience|Narxning daromadga nisbati TScan Therapeutics Inc TCRX|CSBR: Kapitalizatsiya va daromad nisbati|XBIT: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati CVM (cel-sci.com)|OSTX: P/S multiplikatori|Sotuvga nisbatan narx Radiopharm Theranostics Ltd (RADX)|ARTV (Artiva) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati ANL (Adlai Nortye)|Narxning daromadga nisbati Veru Pharma (VERU)|P/S multiplikatori Tempest Tx (TPST)|Narxning daromadga nisbati xiliotx.com XLO|Enochian BioSciences - Narxning daromadga nisbati|Mural Oncology - P/S multiplikatori|KAPA - P/S multiplikatori|OnKure Therapeutics Inc (OKUR) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati CytoMed|Narxning daromadga nisbati curis.com|Kapitalizatsiyaning daromadga nisbati Apollomics, Inc. (APLM)|P/S multiplikatori THAR|Advanced Biomed Corp - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati Genprex GNPX|Narx/daromad koeffitsiyenti Calidi Bio (CLDI)|sunshinebiopharma.com - P/S multiplikatori|Sotuvga nisbatan narx xeneticbio.com|salariuspharma.com (SLRX) - Narxning daromadga nisbati|Purple Biotech Ltd. - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati AON|P/S multiplikatori BeiGene Ltd.|Narxning daromadga nisbati Checkpoint Therapeutics, Inc. (CKPT)|Kapitalizatsiyaning daromadga nisbati Elevation Oncology, Inc. ELEV|P/S multiplikatori ICAD (iCAD Inc.)|Bozor kapitallashuvining daromadga nisbati NTBL|Viracta Therapeutics, Inc. - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati MOR (MorphoSys Inc)|NAYA (NAYA Biosciences Inc) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Ascentage Pharma Group Ltd